ストックスクリーナーアプリを入手
2.19
1.39%
-0.03
前日終値:
$2.16
開ける：
$2.21
24時間の取引高:
12,490
Relative Volume:
0.15
時価総額：
$3.33M
収益：
-
当期純損益:
$-23.14M
株価収益率:
-2.1617
EPS:
-1.0131
ネットキャッシュフロー:
$-29.23M
1週間 パフォーマンス:
+13.90%
1か月 パフォーマンス:
-34.66%
6か月 パフォーマンス:
-73.93%
1年 パフォーマンス:
-84.84%
1日の値動き範囲:
$2.12
$2.21
1週間の範囲:
$1.87
$2.28
52週間の値動き範囲:
$1.5004
$22.06
BiomX Inc Stock (PHGE) Company Profile
名前
BiomX Inc
セクター
電話
972 7 23942377
住所
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
PHGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
2.18 | 3.30M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.66 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
813.09 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
415.46 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
810.37 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
171.66 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-04-15 | 開始されました | Ladenburg Thalmann | Buy |
BiomX Inc (PHGE) 最新ニュース
Is BiomX Inc. stock ready for breakoutProtective Put Strategies & Free Dynamic Profit Opportunities - ulpravda.ru
BiomX announces new preferred stock financing and warrants - MSN
Chart Watch: Will BiomX Inc stock sustain uptrend momentum2025 Key Lessons & Reliable Entry Point Trade Alerts - moha.gov.vn
Growth Report: Is BiomX Inc stock recession proofJuly 2025 EndofMonth & High Win Rate Trade Tips - moha.gov.vn
BiomX announces $3M private placement - MSN
All you need to know about BiomX (PHGE) rating upgrade to buy - MSN
BiomX Announces $3.0 Million Private Placement - The Globe and Mail
BiomX Announces New Preferred Stock Financing and Warrants - TipRanks
BiomX Signs Multiple Material Agreements - TradingView — Track All Markets
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy - Yahoo Finance
BiomX (PHGE) Secures $3M Through Private Investment Initiative - GuruFocus
RSI Suggests Rebound May Be Near in Shree Cement LimitedCash Flow Trends & Free Dynamic Profit Opportunities - earlytimes.in
Is BiomX Inc. stock a buy before product launchesJobs Report & Target Return Focused Stock Picks - DonanımHaber
How interest rate cuts could boost BiomX Inc. stockEarnings Growth Report & High Conviction Investment Ideas - DonanımHaber
Is BiomX Inc. stock resilient to inflationTrade Risk Summary & Weekly Top Performers Watchlists - DonanımHaber
Is BiomX Inc. stock recession proofEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber
Will BiomX Inc. stock outperform foreign stocksJuly 2025 Reactions & High Win Rate Trade Alerts - DonanımHaber
Is BiomX Inc. stock oversold or undervalued2025 Big Picture & Consistent Growth Stock Picks - DonanımHaber
BiomX (NYSEAMERICAN:PHGE) Shares Up 9.9% – Still a Buy? - Defense World
What risks investors should watch in BiomX Inc. stockPortfolio Risk Report & AI Enhanced Trading Alerts - DonanımHaber
Market Rankings: Can BiomX Inc. stock reach $100 price targetJuly 2025 EndofMonth & Safe Entry Zone Tips - Улправда
BiomX collapses into court proceedings after clinical trial fails - CTech
BIOMX INCDECISION FOLLOWS SAFETY REVIEW BY INDEPENDENT DMC - 富途牛牛
BiomX Discontinues Study and Files for Insolvency - TipRanks
BiomX Inc. Discontinues Phase 2b Study and Initiates Insolvency Proceedings - TradingView — Track All Markets
BiomX (NYSE: PHGE) subsidiary seeks insolvency as Phase 2b study ends, BX011 program retained - Stock Titan
BiomX Discontinues Phase 2b Trial for BX004 - The Globe and Mail
Earnings Beat: Is BiomX Inc stock oversold or undervaluedJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - moha.gov.vn
Healthy Upside Potential: BiomX Inc (PHGE) - setenews.com
BiomX Halts Phase 2b Trial Of BX004 In Cystic Fibrosis On High Rates Of Adverse Events - Nasdaq
Stocks Tumble As Bad News Hits Biotech And Energy Sectors - Finimize
BiomX Discontinues Phase 2b Clinical Trial for BX004 - TradingView — Track All Markets
BiomX (PHGE) Halts Phase 2b Trial and Implements Cost-Saving Str - GuruFocus
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review - The Manila Times
BiomX announces discontinuation of phase 2b Bx004 trial following internal review - marketscreener.com
US Stocks Mixed; Dow Falls Over 100 PointsCemtrex (NASDAQ:CETX), Confluent (NASDAQ:CFLT) - Benzinga
BiomX (PHGE) Price Target Increased by 964.52% to 168.30 - Nasdaq
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BiomX (PHGE) Stock Analysis Report | Financials & Insights - Benzinga
Why BiomX Inc. stock could be top winner2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
How BiomX Inc. stock performs in high volatility marketsJuly 2025 Update & Daily Price Action Insights - Newser
BiomX Is Targeting the Infection Threat Returning to Modern WarAnd the Military Is Paying Attention (NYSE: PHGE) - markets.businessinsider.com
How BiomX Inc. stock reacts to Fed tighteningJuly 2025 Update & AI Forecasted Entry/Exit Points - Newser
How BiomX Inc. stock compares with tech leadersJuly 2025 Review & Technical Pattern Alert System - Newser
How forex fluctuations impact BiomX Inc. stockWeekly Stock Recap & High Yield Equity Trading Tips - Newser
Is BiomX Inc. stock ideal for retirement investorsMarket Growth Report & Comprehensive Market Scan Reports - Newser
How BiomX Inc. stock behaves in tightening cyclesAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser
BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis - MSN
BiomX announces 1-for-19 reverse stock split - MSN
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries - Investing.com Canada
BiomX Inc (PHGE) 財務データ
収益
当期純利益
現金流量
EPS
6.23%
大文字化:
|
ボリューム (24 時間):